Literature DB >> 10027500

Behavioral and pharmacologic interventions: the Raynaud's Treatment Study.

B Thompson1, N L Geller, S Hunsberger, M Frederick, R Hill, R G Jacob, E A Smith, P Kaufmann, R R Freedman, F M Wigley, L Bielory.   

Abstract

The Raynaud's Treatment Study (RTS) exemplified clinical trials with treatments that differ qualitatively both in their modes and in their methods of delivery. The RTS compared finger-temperature biofeedback to slow-release nifedipine, a calcium channel blocker, in patients with primary Raynaud's disease. Factors influencing the study design were the nature of the interventions and control measures of the protocol, the possibility of perceived differences by the patients between the treatments once the final protocol was developed, and concern on the part of the investigators over the fact that the primary endpoint was self-reported. This paper presents the final statistical model: a double parallel design with both a placebo group and a nonspecific behavioral control group.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10027500     DOI: 10.1016/s0197-2456(98)00046-4

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN: 0197-2456


  2 in total

1.  Heart Failure Exercise And Training Camp: effects of a multicomponent exercise training intervention in patients with heart failure.

Authors:  Bunny Pozehl; Kathleen Duncan; Melody Hertzog; Joseph F Norman
Journal:  Heart Lung       Date:  2010-07-03       Impact factor: 2.210

Review 2.  Calcium channel blockers for primary Raynaud's phenomenon.

Authors:  Holly Ennis; Michael Hughes; Marina E Anderson; Jack Wilkinson; Ariane L Herrick
Journal:  Cochrane Database Syst Rev       Date:  2016-02-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.